nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP2C8—Simvastatin—atherosclerosis	0.068	0.0946	CbGbCtD
Trimethoprim—CYP2C8—Pravastatin—atherosclerosis	0.0666	0.0926	CbGbCtD
Trimethoprim—CYP2C8—Lovastatin—atherosclerosis	0.0666	0.0926	CbGbCtD
Trimethoprim—CYP2C9—Rosuvastatin—atherosclerosis	0.051	0.071	CbGbCtD
Trimethoprim—ABCB1—Ezetimibe—atherosclerosis	0.0495	0.0689	CbGbCtD
Trimethoprim—CYP2C9—Simvastatin—atherosclerosis	0.0475	0.066	CbGbCtD
Trimethoprim—CYP2C9—Lovastatin—atherosclerosis	0.0464	0.0646	CbGbCtD
Trimethoprim—CYP2C9—Pravastatin—atherosclerosis	0.0464	0.0646	CbGbCtD
Trimethoprim—ABCB1—Simvastatin—atherosclerosis	0.046	0.064	CbGbCtD
Trimethoprim—ABCB1—Lovastatin—atherosclerosis	0.0451	0.0627	CbGbCtD
Trimethoprim—ABCB1—Pravastatin—atherosclerosis	0.0451	0.0627	CbGbCtD
Trimethoprim—CYP3A4—Rosuvastatin—atherosclerosis	0.0297	0.0413	CbGbCtD
Trimethoprim—CYP3A4—Ezetimibe—atherosclerosis	0.0297	0.0413	CbGbCtD
Trimethoprim—CYP3A4—Simvastatin—atherosclerosis	0.0276	0.0384	CbGbCtD
Trimethoprim—CYP3A4—Pravastatin—atherosclerosis	0.027	0.0375	CbGbCtD
Trimethoprim—CYP3A4—Lovastatin—atherosclerosis	0.027	0.0375	CbGbCtD
Trimethoprim—Jaundice cholestatic—Niacin—atherosclerosis	0.00179	0.00906	CcSEcCtD
Trimethoprim—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00176	0.00892	CcSEcCtD
Trimethoprim—TYMS—Fluvastatin—Rosuvastatin—atherosclerosis	0.00168	0.268	CbGdCrCtD
Trimethoprim—Nightmare—Simvastatin—atherosclerosis	0.00165	0.00837	CcSEcCtD
Trimethoprim—TYMS—Simvastatin—Lovastatin—atherosclerosis	0.00161	0.256	CbGdCrCtD
Trimethoprim—TYMS—Simvastatin—Pravastatin—atherosclerosis	0.00161	0.256	CbGdCrCtD
Trimethoprim—Photosensitivity—Lovastatin—atherosclerosis	0.00151	0.00767	CcSEcCtD
Trimethoprim—Nightmare—Pravastatin—atherosclerosis	0.00149	0.00757	CcSEcCtD
Trimethoprim—Vascular purpura—Lovastatin—atherosclerosis	0.00148	0.00752	CcSEcCtD
Trimethoprim—Photosensitivity—Ezetimibe—atherosclerosis	0.00148	0.00752	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00147	0.00746	CcSEcCtD
Trimethoprim—Photosensitivity—Simvastatin—atherosclerosis	0.00141	0.00717	CcSEcCtD
Trimethoprim—Vascular purpura—Simvastatin—atherosclerosis	0.00139	0.00704	CcSEcCtD
Trimethoprim—Purpura—Lovastatin—atherosclerosis	0.00138	0.00698	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00138	0.00697	CcSEcCtD
Trimethoprim—TYMS—Pitavastatin—Rosuvastatin—atherosclerosis	0.00137	0.219	CbGdCrCtD
Trimethoprim—Pancreatitis—Rosuvastatin—atherosclerosis	0.00133	0.00673	CcSEcCtD
Trimethoprim—Purpura—Simvastatin—atherosclerosis	0.00129	0.00653	CcSEcCtD
Trimethoprim—Photosensitivity—Pravastatin—atherosclerosis	0.00128	0.00648	CcSEcCtD
Trimethoprim—Vascular purpura—Pravastatin—atherosclerosis	0.00126	0.00636	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00124	0.0063	CcSEcCtD
Trimethoprim—Depression—Rosuvastatin—atherosclerosis	0.0012	0.0061	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.0012	0.00606	CcSEcCtD
Trimethoprim—Dermatitis bullous—Niacin—atherosclerosis	0.00119	0.00605	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00118	0.006	CcSEcCtD
Trimethoprim—Purpura—Pravastatin—atherosclerosis	0.00116	0.00591	CcSEcCtD
Trimethoprim—Haematuria—Rosuvastatin—atherosclerosis	0.00115	0.00584	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00114	0.00579	CcSEcCtD
Trimethoprim—Eosinophilia—Lovastatin—atherosclerosis	0.00114	0.00576	CcSEcCtD
Trimethoprim—Pancreatitis—Lovastatin—atherosclerosis	0.00112	0.0057	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00112	0.00567	CcSEcCtD
Trimethoprim—Eosinophilia—Ezetimibe—atherosclerosis	0.00111	0.00565	CcSEcCtD
Trimethoprim—Pancreatitis—Ezetimibe—atherosclerosis	0.0011	0.00559	CcSEcCtD
Trimethoprim—Eosinophilia—Simvastatin—atherosclerosis	0.00106	0.00539	CcSEcCtD
Trimethoprim—Pancreatitis—Simvastatin—atherosclerosis	0.00105	0.00533	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00105	0.00531	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00103	0.00521	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00101	0.00514	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00101	0.00513	CcSEcCtD
Trimethoprim—Infestation—Ezetimibe—atherosclerosis	0.001	0.00509	CcSEcCtD
Trimethoprim—Infestation NOS—Ezetimibe—atherosclerosis	0.001	0.00509	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Lovastatin—atherosclerosis	0.001	0.00508	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000984	0.00499	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00098	0.00497	CcSEcCtD
Trimethoprim—Eosinophilia—Pravastatin—atherosclerosis	0.000961	0.00487	CcSEcCtD
Trimethoprim—Depression—Simvastatin—atherosclerosis	0.000954	0.00484	CcSEcCtD
Trimethoprim—Pancreatitis—Pravastatin—atherosclerosis	0.000951	0.00482	CcSEcCtD
Trimethoprim—Mental disorder—Rosuvastatin—atherosclerosis	0.000949	0.00481	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000949	0.00481	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000949	0.00481	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000938	0.00476	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000886	0.00449	CcSEcCtD
Trimethoprim—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000885	0.00449	CcSEcCtD
Trimethoprim—Erythema multiforme—Lovastatin—atherosclerosis	0.000868	0.0044	CcSEcCtD
Trimethoprim—Depression—Pravastatin—atherosclerosis	0.000863	0.00437	CcSEcCtD
Trimethoprim—Angioedema—Rosuvastatin—atherosclerosis	0.000862	0.00437	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000858	0.00435	CcSEcCtD
Trimethoprim—Stomatitis—Niacin—atherosclerosis	0.000857	0.00434	CcSEcCtD
Trimethoprim—Erythema multiforme—Ezetimibe—atherosclerosis	0.000852	0.00432	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000848	0.0043	CcSEcCtD
Trimethoprim—Cough—Rosuvastatin—atherosclerosis	0.000823	0.00417	CcSEcCtD
Trimethoprim—Immune system disorder—Ezetimibe—atherosclerosis	0.000814	0.00413	CcSEcCtD
Trimethoprim—Erythema multiforme—Simvastatin—atherosclerosis	0.000812	0.00412	CcSEcCtD
Trimethoprim—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000812	0.00412	CcSEcCtD
Trimethoprim—Myalgia—Rosuvastatin—atherosclerosis	0.000803	0.00407	CcSEcCtD
Trimethoprim—Arthralgia—Rosuvastatin—atherosclerosis	0.000803	0.00407	CcSEcCtD
Trimethoprim—Mental disorder—Ezetimibe—atherosclerosis	0.000789	0.004	CcSEcCtD
Trimethoprim—Erythema—Ezetimibe—atherosclerosis	0.000784	0.00398	CcSEcCtD
Trimethoprim—Malnutrition—Ezetimibe—atherosclerosis	0.000784	0.00398	CcSEcCtD
Trimethoprim—Confusional state—Rosuvastatin—atherosclerosis	0.000776	0.00394	CcSEcCtD
Trimethoprim—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000755	0.00383	CcSEcCtD
Trimethoprim—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000754	0.00382	CcSEcCtD
Trimethoprim—Mental disorder—Simvastatin—atherosclerosis	0.000753	0.00382	CcSEcCtD
Trimethoprim—Tremor—Lovastatin—atherosclerosis	0.000749	0.0038	CcSEcCtD
Trimethoprim—Erythema—Simvastatin—atherosclerosis	0.000748	0.00379	CcSEcCtD
Trimethoprim—Eye disorder—Niacin—atherosclerosis	0.000737	0.00374	CcSEcCtD
Trimethoprim—Tinnitus—Niacin—atherosclerosis	0.000735	0.00373	CcSEcCtD
Trimethoprim—Erythema multiforme—Pravastatin—atherosclerosis	0.000734	0.00372	CcSEcCtD
Trimethoprim—Angioedema—Lovastatin—atherosclerosis	0.000731	0.0037	CcSEcCtD
Trimethoprim—Tinnitus—Pravastatin—atherosclerosis	0.000724	0.00367	CcSEcCtD
Trimethoprim—Vertigo—Lovastatin—atherosclerosis	0.000718	0.00364	CcSEcCtD
Trimethoprim—Angioedema—Ezetimibe—atherosclerosis	0.000717	0.00363	CcSEcCtD
Trimethoprim—Leukopenia—Lovastatin—atherosclerosis	0.000716	0.00363	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000701	0.00356	CcSEcCtD
Trimethoprim—Tremor—Simvastatin—atherosclerosis	0.000701	0.00355	CcSEcCtD
Trimethoprim—Insomnia—Rosuvastatin—atherosclerosis	0.000696	0.00353	CcSEcCtD
Trimethoprim—Erythema—Niacin—atherosclerosis	0.000687	0.00348	CcSEcCtD
Trimethoprim—Malnutrition—Niacin—atherosclerosis	0.000687	0.00348	CcSEcCtD
Trimethoprim—Cough—Ezetimibe—atherosclerosis	0.000684	0.00347	CcSEcCtD
Trimethoprim—Angioedema—Simvastatin—atherosclerosis	0.000683	0.00346	CcSEcCtD
Trimethoprim—Myalgia—Lovastatin—atherosclerosis	0.000681	0.00345	CcSEcCtD
Trimethoprim—Arthralgia—Lovastatin—atherosclerosis	0.000681	0.00345	CcSEcCtD
Trimethoprim—Anxiety—Lovastatin—atherosclerosis	0.000678	0.00344	CcSEcCtD
Trimethoprim—Dyspepsia—Rosuvastatin—atherosclerosis	0.000678	0.00344	CcSEcCtD
Trimethoprim—Vertigo—Simvastatin—atherosclerosis	0.000672	0.00341	CcSEcCtD
Trimethoprim—Leukopenia—Simvastatin—atherosclerosis	0.000669	0.00339	CcSEcCtD
Trimethoprim—Arthralgia—Ezetimibe—atherosclerosis	0.000668	0.00338	CcSEcCtD
Trimethoprim—Myalgia—Ezetimibe—atherosclerosis	0.000668	0.00338	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000663	0.00336	CcSEcCtD
Trimethoprim—Constipation—Rosuvastatin—atherosclerosis	0.000658	0.00334	CcSEcCtD
Trimethoprim—Confusional state—Lovastatin—atherosclerosis	0.000658	0.00334	CcSEcCtD
Trimethoprim—Anaphylactic shock—Lovastatin—atherosclerosis	0.000653	0.00331	CcSEcCtD
Trimethoprim—Confusional state—Ezetimibe—atherosclerosis	0.000645	0.00327	CcSEcCtD
Trimethoprim—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00064	0.00324	CcSEcCtD
Trimethoprim—Thrombocytopenia—Lovastatin—atherosclerosis	0.000639	0.00324	CcSEcCtD
Trimethoprim—Arthralgia—Simvastatin—atherosclerosis	0.000637	0.00323	CcSEcCtD
Trimethoprim—Myalgia—Simvastatin—atherosclerosis	0.000637	0.00323	CcSEcCtD
Trimethoprim—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000634	0.00322	CcSEcCtD
Trimethoprim—Anxiety—Simvastatin—atherosclerosis	0.000634	0.00322	CcSEcCtD
Trimethoprim—Tremor—Pravastatin—atherosclerosis	0.000633	0.00321	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00063	0.00319	CcSEcCtD
Trimethoprim—Nervous system disorder—Ezetimibe—atherosclerosis	0.000628	0.00318	CcSEcCtD
Trimethoprim—Angioedema—Niacin—atherosclerosis	0.000627	0.00318	CcSEcCtD
Trimethoprim—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000627	0.00318	CcSEcCtD
Trimethoprim—Anorexia—Lovastatin—atherosclerosis	0.000622	0.00315	CcSEcCtD
Trimethoprim—Skin disorder—Ezetimibe—atherosclerosis	0.000622	0.00315	CcSEcCtD
Trimethoprim—Angioedema—Pravastatin—atherosclerosis	0.000618	0.00313	CcSEcCtD
Trimethoprim—Vertigo—Niacin—atherosclerosis	0.000617	0.00313	CcSEcCtD
Trimethoprim—Syncope—Niacin—atherosclerosis	0.000616	0.00312	CcSEcCtD
Trimethoprim—Confusional state—Simvastatin—atherosclerosis	0.000615	0.00312	CcSEcCtD
Trimethoprim—Leukopenia—Niacin—atherosclerosis	0.000615	0.00312	CcSEcCtD
Trimethoprim—Urticaria—Rosuvastatin—atherosclerosis	0.000612	0.0031	CcSEcCtD
Trimethoprim—Anaphylactic shock—Simvastatin—atherosclerosis	0.00061	0.00309	CcSEcCtD
Trimethoprim—Abdominal pain—Rosuvastatin—atherosclerosis	0.000609	0.00309	CcSEcCtD
Trimethoprim—Vertigo—Pravastatin—atherosclerosis	0.000607	0.00308	CcSEcCtD
Trimethoprim—Leukopenia—Pravastatin—atherosclerosis	0.000605	0.00307	CcSEcCtD
Trimethoprim—Loss of consciousness—Niacin—atherosclerosis	0.000604	0.00306	CcSEcCtD
Trimethoprim—Cough—Niacin—atherosclerosis	0.000599	0.00304	CcSEcCtD
Trimethoprim—Thrombocytopenia—Simvastatin—atherosclerosis	0.000598	0.00303	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000594	0.00301	CcSEcCtD
Trimethoprim—Insomnia—Lovastatin—atherosclerosis	0.00059	0.00299	CcSEcCtD
Trimethoprim—Cough—Pravastatin—atherosclerosis	0.00059	0.00299	CcSEcCtD
Trimethoprim—Arthralgia—Niacin—atherosclerosis	0.000585	0.00296	CcSEcCtD
Trimethoprim—Myalgia—Niacin—atherosclerosis	0.000585	0.00296	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000583	0.00296	CcSEcCtD
Trimethoprim—Anorexia—Simvastatin—atherosclerosis	0.000582	0.00295	CcSEcCtD
Trimethoprim—Dyspnoea—Lovastatin—atherosclerosis	0.000582	0.00295	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000581	0.00294	CcSEcCtD
Trimethoprim—Insomnia—Ezetimibe—atherosclerosis	0.000579	0.00293	CcSEcCtD
Trimethoprim—Myalgia—Pravastatin—atherosclerosis	0.000576	0.00292	CcSEcCtD
Trimethoprim—Arthralgia—Pravastatin—atherosclerosis	0.000576	0.00292	CcSEcCtD
Trimethoprim—Dyspepsia—Lovastatin—atherosclerosis	0.000574	0.00291	CcSEcCtD
Trimethoprim—Anxiety—Pravastatin—atherosclerosis	0.000574	0.00291	CcSEcCtD
Trimethoprim—Dyspnoea—Ezetimibe—atherosclerosis	0.000571	0.00289	CcSEcCtD
Trimethoprim—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000567	0.00288	CcSEcCtD
Trimethoprim—Decreased appetite—Lovastatin—atherosclerosis	0.000567	0.00288	CcSEcCtD
Trimethoprim—Dyspepsia—Ezetimibe—atherosclerosis	0.000563	0.00286	CcSEcCtD
Trimethoprim—Anaphylactic shock—Niacin—atherosclerosis	0.00056	0.00284	CcSEcCtD
Trimethoprim—Constipation—Lovastatin—atherosclerosis	0.000558	0.00283	CcSEcCtD
Trimethoprim—Confusional state—Pravastatin—atherosclerosis	0.000556	0.00282	CcSEcCtD
Trimethoprim—Decreased appetite—Ezetimibe—atherosclerosis	0.000556	0.00282	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000556	0.00282	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000553	0.0028	CcSEcCtD
Trimethoprim—Insomnia—Simvastatin—atherosclerosis	0.000552	0.0028	CcSEcCtD
Trimethoprim—Anaphylactic shock—Pravastatin—atherosclerosis	0.000552	0.0028	CcSEcCtD
Trimethoprim—Shock—Niacin—atherosclerosis	0.000551	0.0028	CcSEcCtD
Trimethoprim—Constipation—Ezetimibe—atherosclerosis	0.000547	0.00277	CcSEcCtD
Trimethoprim—Pruritus—Rosuvastatin—atherosclerosis	0.000545	0.00276	CcSEcCtD
Trimethoprim—Skin disorder—Niacin—atherosclerosis	0.000544	0.00276	CcSEcCtD
Trimethoprim—Dyspnoea—Simvastatin—atherosclerosis	0.000544	0.00276	CcSEcCtD
Trimethoprim—Thrombocytopenia—Pravastatin—atherosclerosis	0.00054	0.00274	CcSEcCtD
Trimethoprim—Feeling abnormal—Lovastatin—atherosclerosis	0.000538	0.00273	CcSEcCtD
Trimethoprim—Dyspepsia—Simvastatin—atherosclerosis	0.000537	0.00272	CcSEcCtD
Trimethoprim—Anorexia—Niacin—atherosclerosis	0.000534	0.00271	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000534	0.00271	CcSEcCtD
Trimethoprim—Decreased appetite—Simvastatin—atherosclerosis	0.000531	0.00269	CcSEcCtD
Trimethoprim—Feeling abnormal—Ezetimibe—atherosclerosis	0.000527	0.00267	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000527	0.00267	CcSEcCtD
Trimethoprim—Diarrhoea—Rosuvastatin—atherosclerosis	0.000527	0.00267	CcSEcCtD
Trimethoprim—Anorexia—Pravastatin—atherosclerosis	0.000526	0.00267	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000523	0.00265	CcSEcCtD
Trimethoprim—Constipation—Simvastatin—atherosclerosis	0.000522	0.00265	CcSEcCtD
Trimethoprim—Urticaria—Lovastatin—atherosclerosis	0.000518	0.00263	CcSEcCtD
Trimethoprim—Body temperature increased—Lovastatin—atherosclerosis	0.000516	0.00262	CcSEcCtD
Trimethoprim—Abdominal pain—Lovastatin—atherosclerosis	0.000516	0.00262	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000511	0.00259	CcSEcCtD
Trimethoprim—Dizziness—Rosuvastatin—atherosclerosis	0.000509	0.00258	CcSEcCtD
Trimethoprim—Urticaria—Ezetimibe—atherosclerosis	0.000508	0.00258	CcSEcCtD
Trimethoprim—Insomnia—Niacin—atherosclerosis	0.000507	0.00257	CcSEcCtD
Trimethoprim—Abdominal pain—Ezetimibe—atherosclerosis	0.000506	0.00256	CcSEcCtD
Trimethoprim—Body temperature increased—Ezetimibe—atherosclerosis	0.000506	0.00256	CcSEcCtD
Trimethoprim—Feeling abnormal—Simvastatin—atherosclerosis	0.000503	0.00255	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000503	0.00255	CcSEcCtD
Trimethoprim—Dyspnoea—Niacin—atherosclerosis	0.0005	0.00253	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000499	0.00253	CcSEcCtD
Trimethoprim—Insomnia—Pravastatin—atherosclerosis	0.000499	0.00253	CcSEcCtD
Trimethoprim—Dyspepsia—Niacin—atherosclerosis	0.000493	0.0025	CcSEcCtD
Trimethoprim—Dyspnoea—Pravastatin—atherosclerosis	0.000492	0.00249	CcSEcCtD
Trimethoprim—Decreased appetite—Niacin—atherosclerosis	0.000487	0.00247	CcSEcCtD
Trimethoprim—Dyspepsia—Pravastatin—atherosclerosis	0.000486	0.00246	CcSEcCtD
Trimethoprim—Rash—Rosuvastatin—atherosclerosis	0.000485	0.00246	CcSEcCtD
Trimethoprim—Dermatitis—Rosuvastatin—atherosclerosis	0.000485	0.00246	CcSEcCtD
Trimethoprim—Urticaria—Simvastatin—atherosclerosis	0.000485	0.00246	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Niacin—atherosclerosis	0.000484	0.00245	CcSEcCtD
Trimethoprim—Abdominal pain—Simvastatin—atherosclerosis	0.000482	0.00245	CcSEcCtD
Trimethoprim—Body temperature increased—Simvastatin—atherosclerosis	0.000482	0.00245	CcSEcCtD
Trimethoprim—Headache—Rosuvastatin—atherosclerosis	0.000482	0.00245	CcSEcCtD
Trimethoprim—Hypersensitivity—Lovastatin—atherosclerosis	0.000481	0.00244	CcSEcCtD
Trimethoprim—Decreased appetite—Pravastatin—atherosclerosis	0.00048	0.00243	CcSEcCtD
Trimethoprim—Constipation—Pravastatin—atherosclerosis	0.000472	0.00239	CcSEcCtD
Trimethoprim—Hypersensitivity—Ezetimibe—atherosclerosis	0.000472	0.00239	CcSEcCtD
Trimethoprim—Pruritus—Lovastatin—atherosclerosis	0.000462	0.00234	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Niacin—atherosclerosis	0.000458	0.00232	CcSEcCtD
Trimethoprim—Nausea—Rosuvastatin—atherosclerosis	0.000457	0.00232	CcSEcCtD
Trimethoprim—Feeling abnormal—Pravastatin—atherosclerosis	0.000455	0.00231	CcSEcCtD
Trimethoprim—Pruritus—Ezetimibe—atherosclerosis	0.000453	0.0023	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000451	0.00229	CcSEcCtD
Trimethoprim—Hypersensitivity—Simvastatin—atherosclerosis	0.00045	0.00228	CcSEcCtD
Trimethoprim—Diarrhoea—Lovastatin—atherosclerosis	0.000446	0.00226	CcSEcCtD
Trimethoprim—Urticaria—Niacin—atherosclerosis	0.000445	0.00226	CcSEcCtD
Trimethoprim—Body temperature increased—Niacin—atherosclerosis	0.000443	0.00225	CcSEcCtD
Trimethoprim—Abdominal pain—Niacin—atherosclerosis	0.000443	0.00225	CcSEcCtD
Trimethoprim—Urticaria—Pravastatin—atherosclerosis	0.000438	0.00222	CcSEcCtD
Trimethoprim—Diarrhoea—Ezetimibe—atherosclerosis	0.000438	0.00222	CcSEcCtD
Trimethoprim—Body temperature increased—Pravastatin—atherosclerosis	0.000436	0.00221	CcSEcCtD
Trimethoprim—Abdominal pain—Pravastatin—atherosclerosis	0.000436	0.00221	CcSEcCtD
Trimethoprim—Pruritus—Simvastatin—atherosclerosis	0.000432	0.00219	CcSEcCtD
Trimethoprim—Dizziness—Lovastatin—atherosclerosis	0.000431	0.00219	CcSEcCtD
Trimethoprim—Dizziness—Ezetimibe—atherosclerosis	0.000423	0.00215	CcSEcCtD
Trimethoprim—Diarrhoea—Simvastatin—atherosclerosis	0.000418	0.00212	CcSEcCtD
Trimethoprim—Vomiting—Lovastatin—atherosclerosis	0.000415	0.0021	CcSEcCtD
Trimethoprim—Hypersensitivity—Niacin—atherosclerosis	0.000413	0.00209	CcSEcCtD
Trimethoprim—Rash—Lovastatin—atherosclerosis	0.000411	0.00209	CcSEcCtD
Trimethoprim—Dermatitis—Lovastatin—atherosclerosis	0.000411	0.00208	CcSEcCtD
Trimethoprim—Headache—Lovastatin—atherosclerosis	0.000409	0.00207	CcSEcCtD
Trimethoprim—Vomiting—Ezetimibe—atherosclerosis	0.000407	0.00206	CcSEcCtD
Trimethoprim—Hypersensitivity—Pravastatin—atherosclerosis	0.000407	0.00206	CcSEcCtD
Trimethoprim—Dizziness—Simvastatin—atherosclerosis	0.000404	0.00205	CcSEcCtD
Trimethoprim—Rash—Ezetimibe—atherosclerosis	0.000404	0.00205	CcSEcCtD
Trimethoprim—Dermatitis—Ezetimibe—atherosclerosis	0.000403	0.00204	CcSEcCtD
Trimethoprim—Headache—Ezetimibe—atherosclerosis	0.000401	0.00203	CcSEcCtD
Trimethoprim—Pruritus—Niacin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Trimethoprim—Pruritus—Pravastatin—atherosclerosis	0.00039	0.00198	CcSEcCtD
Trimethoprim—Vomiting—Simvastatin—atherosclerosis	0.000388	0.00197	CcSEcCtD
Trimethoprim—Nausea—Lovastatin—atherosclerosis	0.000388	0.00196	CcSEcCtD
Trimethoprim—Rash—Simvastatin—atherosclerosis	0.000385	0.00195	CcSEcCtD
Trimethoprim—Dermatitis—Simvastatin—atherosclerosis	0.000384	0.00195	CcSEcCtD
Trimethoprim—Diarrhoea—Niacin—atherosclerosis	0.000383	0.00194	CcSEcCtD
Trimethoprim—Headache—Simvastatin—atherosclerosis	0.000382	0.00194	CcSEcCtD
Trimethoprim—Nausea—Ezetimibe—atherosclerosis	0.00038	0.00193	CcSEcCtD
Trimethoprim—Diarrhoea—Pravastatin—atherosclerosis	0.000378	0.00191	CcSEcCtD
Trimethoprim—Dizziness—Niacin—atherosclerosis	0.000371	0.00188	CcSEcCtD
Trimethoprim—Dizziness—Pravastatin—atherosclerosis	0.000365	0.00185	CcSEcCtD
Trimethoprim—Nausea—Simvastatin—atherosclerosis	0.000363	0.00184	CcSEcCtD
Trimethoprim—Vomiting—Niacin—atherosclerosis	0.000356	0.00181	CcSEcCtD
Trimethoprim—Rash—Niacin—atherosclerosis	0.000353	0.00179	CcSEcCtD
Trimethoprim—Dermatitis—Niacin—atherosclerosis	0.000353	0.00179	CcSEcCtD
Trimethoprim—Headache—Niacin—atherosclerosis	0.000351	0.00178	CcSEcCtD
Trimethoprim—Vomiting—Pravastatin—atherosclerosis	0.000351	0.00178	CcSEcCtD
Trimethoprim—Rash—Pravastatin—atherosclerosis	0.000348	0.00176	CcSEcCtD
Trimethoprim—Dermatitis—Pravastatin—atherosclerosis	0.000348	0.00176	CcSEcCtD
Trimethoprim—Headache—Pravastatin—atherosclerosis	0.000346	0.00175	CcSEcCtD
Trimethoprim—Nausea—Niacin—atherosclerosis	0.000333	0.00169	CcSEcCtD
Trimethoprim—Nausea—Pravastatin—atherosclerosis	0.000328	0.00166	CcSEcCtD
Trimethoprim—DHFR—Metabolism—APOE—atherosclerosis	3.38e-05	0.000437	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.35e-05	0.000433	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAV1—atherosclerosis	3.35e-05	0.000433	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CD36—atherosclerosis	3.34e-05	0.000432	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOA1—atherosclerosis	3.34e-05	0.000432	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.26e-05	0.000421	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.23e-05	0.000417	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FABP4—atherosclerosis	3.19e-05	0.000412	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LCAT—atherosclerosis	3.19e-05	0.000412	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—MTHFR—atherosclerosis	3.17e-05	0.000409	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SERPINE1—atherosclerosis	3.17e-05	0.000409	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOA4—atherosclerosis	3.13e-05	0.000405	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARA—atherosclerosis	3.11e-05	0.000402	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP7A1—atherosclerosis	3.08e-05	0.000397	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—atherosclerosis	3.05e-05	0.000394	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS3—atherosclerosis	3.02e-05	0.000391	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AGT—atherosclerosis	3.01e-05	0.000389	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCG1—atherosclerosis	2.96e-05	0.000382	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—atherosclerosis	2.95e-05	0.000381	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—atherosclerosis	2.94e-05	0.000381	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.93e-05	0.000379	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAV1—atherosclerosis	2.92e-05	0.000378	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOA1—atherosclerosis	2.92e-05	0.000377	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.91e-05	0.000376	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.9e-05	0.000375	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—INS—atherosclerosis	2.89e-05	0.000373	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.86e-05	0.00037	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP27A1—atherosclerosis	2.84e-05	0.000367	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.83e-05	0.000365	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.8e-05	0.000362	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LCAT—atherosclerosis	2.78e-05	0.000359	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FABP4—atherosclerosis	2.78e-05	0.000359	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—atherosclerosis	2.77e-05	0.000357	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.76e-05	0.000357	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.75e-05	0.000355	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.73e-05	0.000353	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOA4—atherosclerosis	2.73e-05	0.000352	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOA2—atherosclerosis	2.69e-05	0.000348	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	2.69e-05	0.000348	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	2.69e-05	0.000348	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALOX15—atherosclerosis	2.69e-05	0.000348	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.68e-05	0.000346	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—atherosclerosis	2.66e-05	0.000344	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCG5—atherosclerosis	2.66e-05	0.000344	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.66e-05	0.000344	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLTP—atherosclerosis	2.66e-05	0.000343	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ALB—atherosclerosis	2.65e-05	0.000342	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.64e-05	0.000341	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FABP4—atherosclerosis	2.6e-05	0.000335	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LCAT—atherosclerosis	2.6e-05	0.000335	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LPA—atherosclerosis	2.57e-05	0.000332	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—atherosclerosis	2.57e-05	0.000332	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOA4—atherosclerosis	2.55e-05	0.000329	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.53e-05	0.000328	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—NOS3—atherosclerosis	2.53e-05	0.000327	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—INS—atherosclerosis	2.52e-05	0.000326	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.5e-05	0.000323	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.5e-05	0.000323	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BGN—atherosclerosis	2.49e-05	0.000322	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.48e-05	0.00032	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.47e-05	0.000319	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOA5—atherosclerosis	2.46e-05	0.000319	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.43e-05	0.000314	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.42e-05	0.000313	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.39e-05	0.000309	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.39e-05	0.000308	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	2.37e-05	0.000307	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOA2—atherosclerosis	2.35e-05	0.000303	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALOX15—atherosclerosis	2.35e-05	0.000303	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.35e-05	0.000303	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.35e-05	0.000303	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.35e-05	0.000303	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.32e-05	0.0003	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCG5—atherosclerosis	2.32e-05	0.0003	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.32e-05	0.0003	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—atherosclerosis	2.32e-05	0.000299	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.31e-05	0.000299	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ALB—atherosclerosis	2.31e-05	0.000299	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.3e-05	0.000298	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.3e-05	0.000298	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALOX5—atherosclerosis	2.29e-05	0.000296	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.28e-05	0.000294	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.26e-05	0.000293	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LPA—atherosclerosis	2.24e-05	0.000289	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.22e-05	0.000287	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—NOS3—atherosclerosis	2.21e-05	0.000286	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.19e-05	0.000283	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.19e-05	0.000283	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.19e-05	0.000283	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOA2—atherosclerosis	2.19e-05	0.000283	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BGN—atherosclerosis	2.17e-05	0.00028	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.17e-05	0.00028	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.16e-05	0.00028	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—atherosclerosis	2.16e-05	0.000279	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOA5—atherosclerosis	2.15e-05	0.000277	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.12e-05	0.000274	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LPA—atherosclerosis	2.09e-05	0.00027	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.07e-05	0.000267	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK3—atherosclerosis	2.06e-05	0.000266	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NAMPT—atherosclerosis	2.06e-05	0.000266	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.05e-05	0.000265	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.04e-05	0.000264	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LIPC—atherosclerosis	2.04e-05	0.000264	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOC3—atherosclerosis	2.03e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BGN—atherosclerosis	2.03e-05	0.000262	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—atherosclerosis	2.02e-05	0.000261	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LDLR—atherosclerosis	2.02e-05	0.000261	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.01e-05	0.00026	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOA5—atherosclerosis	2.01e-05	0.000259	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—atherosclerosis	2e-05	0.000258	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALOX5—atherosclerosis	2e-05	0.000258	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CETP—atherosclerosis	1.97e-05	0.000255	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.95e-05	0.000252	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.93e-05	0.00025	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.92e-05	0.000248	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.91e-05	0.000247	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.86e-05	0.000241	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.84e-05	0.000237	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.82e-05	0.000235	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NAMPT—atherosclerosis	1.79e-05	0.000231	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.78e-05	0.00023	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LIPC—atherosclerosis	1.78e-05	0.00023	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOC3—atherosclerosis	1.77e-05	0.000229	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LDLR—atherosclerosis	1.76e-05	0.000227	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.72e-05	0.000223	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CETP—atherosclerosis	1.72e-05	0.000222	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LCAT—atherosclerosis	1.71e-05	0.000221	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FABP4—atherosclerosis	1.71e-05	0.000221	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.69e-05	0.000218	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOA4—atherosclerosis	1.68e-05	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.67e-05	0.000216	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.66e-05	0.000215	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LIPC—atherosclerosis	1.66e-05	0.000215	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOC3—atherosclerosis	1.65e-05	0.000213	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.65e-05	0.000213	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SCARB1—atherosclerosis	1.64e-05	0.000212	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LDLR—atherosclerosis	1.64e-05	0.000212	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.61e-05	0.000208	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CETP—atherosclerosis	1.6e-05	0.000207	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000201	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.54e-05	0.000198	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.53e-05	0.000197	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.52e-05	0.000197	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—atherosclerosis	1.51e-05	0.000195	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.5e-05	0.000193	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.45e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.45e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.45e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOA2—atherosclerosis	1.45e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.45e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.43e-05	0.000185	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—atherosclerosis	1.39e-05	0.00018	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCA1—atherosclerosis	1.38e-05	0.000179	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LPA—atherosclerosis	1.38e-05	0.000178	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.36e-05	0.000176	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BGN—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOA5—atherosclerosis	1.32e-05	0.000171	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.31e-05	0.000169	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOB—atherosclerosis	1.31e-05	0.000169	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000167	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.27e-05	0.000165	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.27e-05	0.000164	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LPL—atherosclerosis	1.25e-05	0.000161	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.23e-05	0.000159	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPX1—atherosclerosis	1.22e-05	0.000157	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HMOX1—atherosclerosis	1.19e-05	0.000153	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CD36—atherosclerosis	1.18e-05	0.000153	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—atherosclerosis	1.16e-05	0.00015	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOB—atherosclerosis	1.14e-05	0.000147	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.12e-05	0.000145	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.11e-05	0.000143	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—atherosclerosis	1.11e-05	0.000143	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.1e-05	0.000143	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARA—atherosclerosis	1.1e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000141	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LPL—atherosclerosis	1.09e-05	0.00014	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LDLR—atherosclerosis	1.08e-05	0.00014	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AGT—atherosclerosis	1.07e-05	0.000138	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOB—atherosclerosis	1.06e-05	0.000137	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPX1—atherosclerosis	1.06e-05	0.000137	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CETP—atherosclerosis	1.06e-05	0.000137	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—atherosclerosis	1.04e-05	0.000135	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—atherosclerosis	1.03e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOA1—atherosclerosis	1.03e-05	0.000133	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CD36—atherosclerosis	1.03e-05	0.000133	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—atherosclerosis	1.02e-05	0.000131	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LPL—atherosclerosis	1.01e-05	0.000131	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.01e-05	0.000131	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPX1—atherosclerosis	9.9e-06	0.000128	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—atherosclerosis	9.78e-06	0.000126	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CD36—atherosclerosis	9.64e-06	0.000125	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARA—atherosclerosis	9.59e-06	0.000124	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.56e-06	0.000124	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—atherosclerosis	9.43e-06	0.000122	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AGT—atherosclerosis	9.29e-06	0.00012	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—atherosclerosis	9.13e-06	0.000118	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—atherosclerosis	9.1e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—atherosclerosis	9.1e-06	0.000118	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—atherosclerosis	9.02e-06	0.000117	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOA1—atherosclerosis	9e-06	0.000116	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARA—atherosclerosis	8.96e-06	0.000116	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—INS—atherosclerosis	8.92e-06	0.000115	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AGT—atherosclerosis	8.68e-06	0.000112	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.52e-06	0.00011	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—atherosclerosis	8.5e-06	0.00011	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—atherosclerosis	8.42e-06	0.000109	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOA1—atherosclerosis	8.4e-06	0.000109	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—atherosclerosis	8.21e-06	0.000106	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALB—atherosclerosis	8.18e-06	0.000106	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—atherosclerosis	7.93e-06	0.000102	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NOS3—atherosclerosis	7.83e-06	0.000101	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—INS—atherosclerosis	7.77e-06	0.0001	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—atherosclerosis	7.67e-06	9.92e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—atherosclerosis	7.41e-06	9.57e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.31e-06	9.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—INS—atherosclerosis	7.26e-06	9.39e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—atherosclerosis	7.16e-06	9.25e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALB—atherosclerosis	7.13e-06	9.21e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOB—atherosclerosis	7.01e-06	9.05e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NOS3—atherosclerosis	6.82e-06	8.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.81e-06	8.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LPL—atherosclerosis	6.69e-06	8.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALB—atherosclerosis	6.66e-06	8.61e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPX1—atherosclerosis	6.53e-06	8.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NOS3—atherosclerosis	6.37e-06	8.23e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CD36—atherosclerosis	6.36e-06	8.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—atherosclerosis	6.24e-06	8.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.02e-06	7.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARA—atherosclerosis	5.91e-06	7.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.83e-06	7.53e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AGT—atherosclerosis	5.72e-06	7.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—atherosclerosis	5.61e-06	7.25e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—atherosclerosis	5.56e-06	7.18e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOA1—atherosclerosis	5.54e-06	7.16e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.06e-06	6.54e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—atherosclerosis	4.88e-06	6.31e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—INS—atherosclerosis	4.79e-06	6.19e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALB—atherosclerosis	4.39e-06	5.68e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NOS3—atherosclerosis	4.2e-06	5.43e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.84e-06	4.97e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—atherosclerosis	3.6e-06	4.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—atherosclerosis	3.13e-06	4.05e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—atherosclerosis	2.93e-06	3.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—atherosclerosis	1.93e-06	2.5e-05	CbGpPWpGaD
